Lessons learned from a complete remission of advanced metastatic pancreatic ductal adenocarcinoma.
نویسندگان
چکیده
Blessy M. Mathew, MD1 Adel Y. Daas, MD2 Barbara A. Centeno, MD3 Sarah Hoffe, MD3 Tiffany Valone, PA3 Manish Patel, MD3 Gregory M. Springett, MD, PhD3 1Department of Internal Medicine, Emory University, Atlanta, Georgia; 2Division of Digestive Diseases and Nutrition, James A. Haley Veterans Administration Hospital, Tampa, Florida; 3Department of Oncologic Sciences, Moffitt Cancer Center, University of South Florida, Tampa, Florida
منابع مشابه
The 5-year survival rate for patients with histologically confirmed metastatic ductal adenocarcinoma of the pancreas approaches 0%,with a median overall survival
Cancer Control 295 Introduction The 5-year survival rate for patients with histologically confirmed metastatic ductal adenocarcinoma of the pancreas approaches 0%,with a median overall survival of 5 to 6 months.1-3 Long-term survival after a diagnosis of pancreatic cancer is attained only in patients who are diagnosed prior to the development of distant metastasis and are able to undergo comple...
متن کاملLong-term survival following resection of brain metastases from pancreatic cancer.
Brain metastases originating from pancreatic cancer are associated with a dismal prognosis and, generally, therapeutic options remain palliative. We present the cases of two patients that developed brain metastases after resection of a pancreatic ductal adenocarcinoma. Brain metastases were resected successfully and neither patients developed any further tumor recurrence. These cases demonstrat...
متن کاملEvolving treatment landscape for early and advanced pancreatic cancer
Pancreatic ductal adenocarcinoma is an infrequent cancer with a high disease related mortality rate, even in the context of early stage disease. Until recently, the rate of death from pancreatic cancer has remained largely similar whereby gemcitabine monotherapy was the mainstay of systemic treatment for most stages of disease. With the discovery of active multi-agent chemotherapy regimens, nam...
متن کاملPreoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma
e15677 Background: Almost 30% of patients with pancreatic cancer present with locally advanced tumours in absence of distant metastasis. Because surgical resection is often contraindicated by vascular invasion, this disease has a dismal prognosis. The combination of gemcitabine with concurrent radiation therapy is a promising approach that is being investigated in patients' unresectable pancrea...
متن کاملPercutaneous intratumoral injection of gemcitabine plus cisplatin mixed with fibrin glue for advanced pancreatic carcinoma
RATIONALE The aim of this study was to determine the effectiveness of intratumoral injection of chemotherapeutics in improving the quality of life and survival of patients with pancreatic carcinoma. PATIENT CONCERNS We present a case series of 5 patients with unresectable pancreatic adenocarcinoma. DIAGNOSES Patients diagnosed with unresectable poorly differentiated pancreatic ductal adenoc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Clinical advances in hematology & oncology : H&O
دوره 10 5 شماره
صفحات -
تاریخ انتشار 2012